Both are GHRH analogs but they get treated very differently in the community. Let's break it down.
Tesamorelin:
CJC-1295 (with DAC):
Key difference: Tesamorelin has real clinical data behind it. CJC-1295 has broader community experience but less formal research.
The practical question: If you have access to both, which makes more sense for your research goals? Tesamorelin's visceral fat data is compelling, but CJC+Ipa is the more flexible stack.
What are people running and why did you choose one over the other?
I wanted to share my firsthand experience comparing Tesamorelin and CJC.
While I noticed that CJC provided much better sleep than Tesamorelin, the side effects ultimately forced me to remove it from my lineup. I experienced red, itchy histamine reactions and flushing at the injection site that felt like a sting. Most concerning, however, was a recent incident where I suddenly developed hives and a severe allergic reaction, accompanied by nausea and violent vomiting.
Because I don't experience any significant side effects with Tesamorelin, I have decided to switch back to it.
